APAC

Updated June 2025

Kalorama Information’s 30-Country IVD Market Atlas, 2025 provides a comprehensive analysis of the in vitro diagnostic (IVD) markets across 30 key countries, including the U.S., China, Germany, UK, Saudi Arabia, India, UAE, France, Vietnam, and Turkey, among others. This in-depth report delivers detailed market sizing, forecasts for 2029 and 2030,…

Gain valuable insights into South Korea’s in vitro diagnostics (IVD) market with Kalorama Information’s comprehensive report, The IVD Market in South Korea, 2024. We offer a detailed analysis of South Korea’s IVD revenues for 2023 and forecasts for 2028, segmented into key categories such as clinical chemistry, immunoassay, microbiology/molecular testing, point-of-care (POC),…

The in vitro diagnostics (IVD) market is a global multi-billion-dollar industry, with significant revenue generated outside the United States. To facilitate successful business planning, it’s crucial to assess regional and country-level IVD markets. Kalorama’s 30 Country IVD Market Atlas report offers detailed insights into international markets, aiding in forecast modeling and strategic planning.

 

Key…

In Vitro Diagnostics (IVD) in Malaysia, Singapore and Indonesia, 2022 by Kalorama Information presents a comprehensive market research report focusing on the burgeoning IVD market in Southeast Asia. As part of the fast-growing Asia Pacific (APAC) region, Southeast Asia offers significant opportunities for IVD companies, with Malaysia, Indonesia, and Singapore at the forefront.

 

Report…

Kalorama Information is proud to announce a comprehensive new market research report, offering an in-depth overview of the In Vitro Diagnostics (IVD) market in India. This report delves into the IVD discipline, covering reagents, consumables, calibrators, and controls across various sub-segments, providing a detailed analysis of market trends and influences.

 

Report Highlights:

• Clinical…

As an in vitro diagnostics (IVD) market, China ranks just behind the large, developed economies of the United States, Western Europe, and Japan. The Chinese healthcare system faces challenges similar to those in less developed countries, alongside burdens common in affluent countries such as diabetes, cardiovascular disease, and aging-related diseases. China’s potential as an IVD…